INTRODUCTION
Nature is mother of mankind. It blesses us through various minerals and herbs to live a healthy and wealthy long life. Since ancient times, humanity has depended on the mixture of the plant and mineral resources for food clothing, protection and traditional medicine to cure a number of diseases. Arogyavardhini Compound is an emerging herbo-mineral formulation of thirteen ingredients ( , and Guggulu
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. Lasuna also possesses anti-hyperlipidemic, anti-diabetic and anti-hypertensive activity. 16 So the combination of Arogyavardhini Rasa and Lasuna may exert significant effect on metabolic syndrome.
Metabolic syndrome is a disorder of energy utilization and storage, diagnosed by a co-occurrence of three out of five of the following medical conditions: abdominal (central) obesity, elevated blood pressure, elevated fasting plasma glucose, high serum triglycerides, and low high-density cholesterol (HDL) levels. Metabolic syndrome increases the risk of developing cardiovascular disease, particularly heart failure, and diabetes. Some studies have shown the prevalence in the USA to be an estimated 34% of the adult population and the prevalence increases with age.
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During the past decades there has been increasing acceptance and public interest in natural products and therapies in both developing and developed countries. So, we cannot assure drug industries insulation from adulterations and quality decrement. Therefore, quality control for efficacy and safety of herbal products is of main concern. 18, 19 Maintaining the quality standards of the formulation is a challenge. The development of this traditional system of medicine with the perspective of safety, efficacy and quality will help not only to preserve the traditional heritage but also to rationalize the use of the natural products in healthcare. 20, 21 Initial steps in quality standardization of compound formulation is to establish the presence of each ingredient in the finished product, 22 followed by the pharmaceutical analysis. In the present study, Arogyavardhini Compound was subjected to pharmacognostical (powder microscopy), HPTLC, densitogram and pharmaceutical evaluation for various physicochemical parameters in order to prepare a preliminary profile of formulation for future.
MATERIAL AND METHODS

Collection of raw materials:
All the raw drug materials were collected from the pharmacy attached with institute. The ingredients and parts used of the drugs are given in table-1. Pharmacognostical study: Raw drugs were identified and authenticated by the Pharmacognosy laboratory. The identification was carried out based on organoleptic characters of powder (Churna), 23 later pharmacognostical evaluation of the powder (Churna) was carried out. Powder (Churna) was dissolved in small quantity of distilled water, filtered through filter paper, studied under the Corlzeiss trinocular microscope attached with camera, with stain and without stain. The microphotographs were also taken under the microscope.
24, 25
Method of preparation of Arogyavardhini Compound: Arogyavardhini rasa was prepared by standard method mentioned in Ayurveda. Kajjali (black mercury sulphide, Loha bhasma (incinerated iron) Abhraka Bhasma (incinerated mica), Tamrabhasma (incinerated copper),
Haritaki powder, Bibhitaka powder, Amalaki powder, Shuddh Shilajita (Black Bitmin), Erandmula, Suddha Guggulu and Katuki powder were weighed accurately. First Kajjali and Bhasma placed in Khalva and mixed properly, than remaining powder added in this mixture and mixed thoroughly. Nimbpatra Svarasa was added till the mixture immersed completely and trituration was carried out till the mixture get semisolid form and dried. Same procedure was followed for second Bhavana also. 26 Single bulb Lasuna was collected from green vegetable grocer market of local area. Lasuna was first made into 
Dried paste of Lasuna was made into fine powder and sieved in mesh no.80. The equal quantity of Lasuna powder was mixed well with Arogyavardhini Rasa in mass mixing machine till the homogeneous mixture was obtained.
Pharmaceutical evaluation:
Arogyavardhini Compound was analyzed by using qualitative and quantitative parameters at pharmaceutical laboratory. The common parameters mentioned for Churna in Ayurved pharmacopeia of India and C.C.R.A.S guidelines are total Ash value, pH value, water and methanol soluble extracts. 27 On its base the parameters were selected. Presence of more moisture contents in a sample can create preservative problems of Churna. Hence loss on drying was also selected as one of the parameter. 28, 29 High performance thin layer chromatography: Methanol extract of Arogyavardhini Compound was spotted on pre-coated silica gel GF CO 254 aluminum plate as 5 mm bands, 5 mm apart and 1 cm from the edge of the plates, by means of camag, linomate V sample applicator fitted with a 100 µL. Hamilton syringe was used as the mobile phase. After development, densitometry scanning was performed with a camage TLC scanner III reflectance absorbance mode at 254 nm and 366 nm under control of win CATS software (V 1.2.1 manufactured by CAMAGE Switzerland).The slit dimensions were 6.00 x 0.45 mm and the scanning speed was 20 mm per second.
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OBSERVATIONS AND RESULTS
The initial purpose of the study was to confirm the authenticity of the drugs used in the preparation of Arogyavardhini Compound. For this, coarse powder of all the ingredients was subjected to organoleptic and microscopic evaluation separately to confirm the genuineness of all the raw drugs. Later after the preparation of formulation, pharmacognostical evaluation was carried out.
Organoleptic evaluation: Organoleptic features like color; odor and taste of the Arogyavardhini Compound were recorded and are placed in table no 2. Compound is free from unwanted organic compounds and production site was good enough keeping sample free from dust and other solid matters. The 13.5% w/w of water soluble extractives and 17.2% w/w methanol soluble extractives were present in Arogyavardhini Compound indicating that the drug is having good solubility in water.
[31]
In HPTLC study 9 spots at 254 nm and 7spots at 366 nm were obtained, indicating its possible components of matrix which may possess its therapeutic effect.
CONCLUSION
The ingredients were identified and authenticated pharmacognostically and were used for the preparation. The formulation was subjected to pharmacognostical study reveal genuineness as that all the ingredient microscopical characters were observed. Physicochemical and HPTLC studies inferred that the formulation meets the minimum quality standards as reported in the API at a preliminary level. The inference from this study may be used as reference standard in the further quality control researches.
